首页 | 本学科首页   官方微博 | 高级检索  
检索        

心肌缺血再灌注损伤中医药研究进展
引用本文:周朝伟,严冬.心肌缺血再灌注损伤中医药研究进展[J].辽宁中医药大学学报,2014(3):217-220.
作者姓名:周朝伟  严冬
作者单位:[1]南京中医药大学,江苏南京210029 [2]南京中医药大学附属医院,江苏南京210029
摘    要:大量实验研究发现,在心肌缺血再灌注损伤时,中药复方及中药有效提取物,能有效的抑制氧自由基的形成,减少胞质内Ca2+,控制炎症反应,从而达到保护损伤心肌、提高心肌细胞生存产率的目的。因此进一步研究和发展中医药,对预防和保护MIRI具有重要意义。

关 键 词:心肌缺血/再灌注损伤  中医治疗  研究进展

Research Progress of TCM on Myocardial Ischemia-Reperfusion Injury
ZHOU Chaowei,YAN Dong.Research Progress of TCM on Myocardial Ischemia-Reperfusion Injury[J].Journal of Liaoning University of Traditional Chinese Medicine,2014(3):217-220.
Authors:ZHOU Chaowei  YAN Dong
Institution:1.Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu, China; 2. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu, China )
Abstract:A large number of studies have found that the compound Chinese medicine and Chinese medicine extract can effectively inhibit the formation of oxygen free radicals when the myocardial ischemia-reperfusion injury happens. Meanwhile, they also can reduce Ca^2+ in cells and control inflammation so as to protect the injuried myocardial tissue and improve the production rate of myocardial cell survival. Therefore, the further research and development of TCM is of great significance for preventing and protecting MIRI.
Keywords:myocardial ischemia-reperfusion injury  treatment of traditional Chinese medicine  research progress
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号